DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
BIT:1DXCM - Euronext Milan - US2521311074 - Common Stock - Currency: EUR
Taking everything into account, 1DXCM scores 6 out of 10 in our fundamental rating. 1DXCM was compared to 59 industry peers in the Health Care Equipment & Supplies industry. 1DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. 1DXCM is valued quite expensively, but it does show have an excellent growth rating. With these ratings, 1DXCM could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year 1DXCM was profitable.
In the past year 1DXCM had a positive cash flow from operations.
In the past 5 years 1DXCM has always been profitable.
1DXCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1DXCM's Return On Assets of 7.93% is amongst the best of the industry. 1DXCM outperforms 81.54% of its industry peers.
1DXCM has a Return On Equity of 23.61%. This is amongst the best in the industry. 1DXCM outperforms 89.23% of its industry peers.
1DXCM has a Return On Invested Capital of 14.54%. This is amongst the best in the industry. 1DXCM outperforms 93.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1DXCM is above the industry average of 8.57%.
The 3 year average ROIC (11.25%) for 1DXCM is below the current ROIC(14.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.93% | ||
| ROE | 23.61% | ||
| ROIC | 14.54% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
1DXCM has a better Profit Margin (12.90%) than 78.46% of its industry peers.
1DXCM's Profit Margin has improved in the last couple of years.
1DXCM has a better Operating Margin (16.54%) than 73.85% of its industry peers.
In the last couple of years the Operating Margin of 1DXCM has grown nicely.
1DXCM has a Gross Margin (60.72%) which is in line with its industry peers.
1DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.54% | ||
| PM (TTM) | 12.9% | ||
| GM | 60.72% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1DXCM is creating some value.
The number of shares outstanding for 1DXCM has been increased compared to 1 year ago.
The number of shares outstanding for 1DXCM has been increased compared to 5 years ago.
Compared to 1 year ago, 1DXCM has an improved debt to assets ratio.
2.2 Solvency
1DXCM has an Altman-Z score of 6.16. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
1DXCM's Altman-Z score of 6.16 is amongst the best of the industry. 1DXCM outperforms 89.23% of its industry peers.
1DXCM has a debt to FCF ratio of 4.35. This is a neutral value as 1DXCM would need 4.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.35, 1DXCM is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
1DXCM has a Debt/Equity ratio of 0.57. This is a neutral value indicating 1DXCM is somewhat dependend on debt financing.
1DXCM has a worse Debt to Equity ratio (0.57) than 64.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.35 | ||
| Altman-Z | 6.16 |
ROIC/WACC1.74
WACC8.38%
2.3 Liquidity
A Current Ratio of 1.50 indicates that 1DXCM should not have too much problems paying its short term obligations.
1DXCM's Current ratio of 1.50 is in line compared to the rest of the industry. 1DXCM outperforms 44.62% of its industry peers.
1DXCM has a Quick Ratio of 1.32. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
1DXCM has a better Quick ratio (1.32) than 66.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
1DXCM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.60%.
Measured over the past years, 1DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
1DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.11%.
The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-0.6%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%0%
Revenue 1Y (TTM)9.11%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%12.49%
3.2 Future
The Earnings Per Share is expected to grow by 22.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.01% on average over the next years. This is quite good.
EPS Next Y25.28%
EPS Next 2Y25.18%
EPS Next 3Y24.59%
EPS Next 5Y22.56%
Revenue Next Year14.72%
Revenue Next 2Y14.99%
Revenue Next 3Y14.84%
Revenue Next 5Y14.01%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 53.18 indicates a quite expensive valuation of 1DXCM.
The rest of the industry has a similar Price/Earnings ratio as 1DXCM.
The average S&P500 Price/Earnings ratio is at 26.57. 1DXCM is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 33.86, which means the current valuation is very expensive for 1DXCM.
61.54% of the companies in the same industry are cheaper than 1DXCM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 1DXCM to the average of the S&P500 Index (22.41), we can say 1DXCM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.18 | ||
| Fwd PE | 33.86 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1DXCM indicates a slightly more expensive valuation: 1DXCM is more expensive than 60.00% of the companies listed in the same industry.
1DXCM's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.68 | ||
| EV/EBITDA | 35.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
1DXCM's earnings are expected to grow with 24.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.1
PEG (5Y)1.82
EPS Next 2Y25.18%
EPS Next 3Y24.59%
5. Dividend
5.1 Amount
1DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (6/3/2025, 7:00:00 PM)
76.05
+76.05 (+Infinity%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.23%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap29.82B
Analysts85.45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.87%
Min EPS beat(2)-11.66%
Max EPS beat(2)-4.09%
EPS beat(4)2
Avg EPS beat(4)-1.25%
Min EPS beat(4)-11.66%
Max EPS beat(4)9.24%
EPS beat(8)6
Avg EPS beat(8)14.5%
EPS beat(12)9
Avg EPS beat(12)12.8%
EPS beat(16)11
Avg EPS beat(16)12.29%
Revenue beat(2)0
Avg Revenue beat(2)-0.7%
Min Revenue beat(2)-1.2%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-0.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)4
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.11%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.18 | ||
| Fwd PE | 33.86 | ||
| P/S | 8.28 | ||
| P/FCF | 59.68 | ||
| P/OCF | 35.61 | ||
| P/B | 15.15 | ||
| P/tB | 15.98 | ||
| EV/EBITDA | 35.48 |
EPS(TTM)1.43
EY1.88%
EPS(NY)2.25
Fwd EY2.95%
FCF(TTM)1.27
FCFY1.68%
OCF(TTM)2.14
OCFY2.81%
SpS9.19
BVpS5.02
TBVpS4.76
PEG (NY)2.1
PEG (5Y)1.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.93% | ||
| ROE | 23.61% | ||
| ROCE | 18.47% | ||
| ROIC | 14.54% | ||
| ROICexc | 53.32% | ||
| ROICexgc | 60.37% | ||
| OM | 16.54% | ||
| PM (TTM) | 12.9% | ||
| GM | 60.72% | ||
| FCFM | 13.87% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexcg growth 3Y55.18%
ROICexcg growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 4.35 | ||
| Debt/EBITDA | 1.42 | ||
| Cap/Depr | 172.69% | ||
| Cap/Sales | 9.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.79% | ||
| Profit Quality | 107.47% | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 6.16 |
F-Score6
WACC8.38%
ROIC/WACC1.74
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.6%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%0%
EPS Next Y25.28%
EPS Next 2Y25.18%
EPS Next 3Y24.59%
EPS Next 5Y22.56%
Revenue 1Y (TTM)9.11%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%12.49%
Revenue Next Year14.72%
Revenue Next 2Y14.99%
Revenue Next 3Y14.84%
Revenue Next 5Y14.01%
EBIT growth 1Y2.68%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year76.08%
EBIT Next 3Y38.17%
EBIT Next 5Y31.52%
FCF growth 1Y38.27%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y27.88%
OCF growth 3Y30.77%
OCF growth 5Y25.76%